• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4632385)   Today's Articles (6246)   Subscriber (49897)
For:  [Subscribe] [Scholar Register]
Number Cited by Other Article(s)
1
Lim HY, Dolzhenko AV. 1,3,5-Triazine as a promising scaffold in the development of therapeutic agents against breast cancer. Eur J Med Chem 2024;276:116680. [PMID: 39018924 DOI: 10.1016/j.ejmech.2024.116680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2024] [Revised: 07/09/2024] [Accepted: 07/12/2024] [Indexed: 07/19/2024]
2
Gowdru Srinivasa M, B C R, Prabhu A, Rani V, Ghate SD, Kumar B R P. Development of novel thiazolidine-2,4-dione derivatives as PPAR-γ agonists through design, synthesis, computational docking, MD simulation, and comprehensive in vitro and in vivo evaluation. RSC Med Chem 2023;14:2401-2416. [PMID: 37974963 PMCID: PMC10650958 DOI: 10.1039/d3md00273j] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2023] [Accepted: 09/06/2023] [Indexed: 11/19/2023]  Open
3
Gupta A, Bhat HR, Singh UP. Discovery of imeglimin-inspired novel 1,3,5-triazine derivatives as antidiabetic agents in streptozotocin-induced diabetes in Wistar rats via inhibition of DPP-4. RSC Med Chem 2023;14:1512-1536. [PMID: 37593577 PMCID: PMC10429709 DOI: 10.1039/d3md00085k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2023] [Accepted: 05/21/2023] [Indexed: 08/19/2023]  Open
4
Song M, Chen Y. Local anaesthetic procaine derivatives protect rat against diabetic nephropathy via inhibition of DPP-4, inflammation and oxidative stress. Chem Biol Drug Des 2023;102:26-37. [PMID: 37076428 DOI: 10.1111/cbdd.14252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Revised: 03/16/2023] [Accepted: 04/04/2023] [Indexed: 04/21/2023]
5
Gupta A, Bhat HR, Singh UP. Discovery of novel 1,3,5-triazine derivatives as an antidiabetic agent in Wistar rats via inhibition of DPP-4. Future Med Chem 2023;15:829-852. [PMID: 37307171 DOI: 10.4155/fmc-2022-0312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2022] [Accepted: 05/10/2023] [Indexed: 06/14/2023]  Open
6
Adhikari N, Choudhury AAK, Shakya A, Ghosh SK, Patgiri SJ, Singh UP, Bhat HR. Design and development of novel N ‐(4‐aminobenzoyl)‐ l ‐glutamic acid conjugated 1,3,5‐triazine derivatives as Pf ‐DHFR inhibitor: An in‐silico and in‐vitro study. J Biochem Mol Toxicol 2022;37:e23290. [PMID: 36541419 DOI: 10.1002/jbt.23290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2022] [Revised: 10/17/2022] [Accepted: 12/09/2022] [Indexed: 12/24/2022]
7
Mohammad BD, Baig MS, Bhandari N, Siddiqui FA, Khan SL, Ahmad Z, Khan FS, Tagde P, Jeandet P. Heterocyclic Compounds as Dipeptidyl Peptidase-IV Inhibitors with Special Emphasis on Oxadiazoles as Potent Anti-Diabetic Agents. Molecules 2022;27:molecules27186001. [PMID: 36144735 PMCID: PMC9502781 DOI: 10.3390/molecules27186001] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2022] [Revised: 09/11/2022] [Accepted: 09/12/2022] [Indexed: 11/25/2022]  Open
8
Tuersuntuoheti T, Pan F, Zhang M, Wang Z, Han J, Sun Z, Song W. Prediction of DPP‐IV Inhibitory Potentials of Polyphenols Existed in Qingke Barley Fresh Noodles: In Vitro and In Silico Analyses. J FOOD PROCESS PRES 2022. [DOI: 10.1111/jfpp.16808] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
9
Mondal J, Sivaramakrishna A. Functionalized Triazines and Tetrazines: Synthesis and Applications. Top Curr Chem (Cham) 2022;380:34. [PMID: 35737142 DOI: 10.1007/s41061-022-00385-7] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2022] [Accepted: 05/13/2022] [Indexed: 12/19/2022]
10
Sun J, Liu HY, Zhang YH, Fang ZY, Lv PC. Design, synthesis and bioactivity evaluation of thiazolidinedione derivatives as partial agonists targeting PPARγ. Bioorg Chem 2021;116:105342. [PMID: 34536928 DOI: 10.1016/j.bioorg.2021.105342] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Revised: 08/26/2021] [Accepted: 09/06/2021] [Indexed: 11/17/2022]
11
Kumar S, Mittal A, Mittal A. A review upon medicinal perspective and designing rationale of DPP-4 inhibitors. Bioorg Med Chem 2021;46:116354. [PMID: 34428715 DOI: 10.1016/j.bmc.2021.116354] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2021] [Revised: 07/26/2021] [Accepted: 07/30/2021] [Indexed: 12/13/2022]
12
Kashyap A, Choudhury AAK, Saha A, Adhikari N, Ghosh SK, Shakya A, Patgiri SJ, Bhattacharyya DR, Singh UP, Bhat HR. Microwave-assisted synthesis of hybrid PABA-1,3,5-triazine derivatives as an antimalarial agent. J Biochem Mol Toxicol 2021;35:e22860. [PMID: 34313355 DOI: 10.1002/jbt.22860] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2020] [Revised: 04/21/2021] [Accepted: 07/14/2021] [Indexed: 12/25/2022]
13
Singh M, Jamra R, Mehra S, Rattan S, Singh V. Potassium Tert ‐Butoxide‐Promoted Synthesis of Fluorescent β‐Carboline Tethered 1,3,5‐Triazines and Assessment of Their Luminescent Properties. ASIAN J ORG CHEM 2021. [DOI: 10.1002/ajoc.202100281] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
14
Dong L, Fang L, Dai X, Zhang J, Wang J, Xu P. Antibacterial and anti-inflammatory activity of valproic acid-pyrazole conjugates as a potential agent against periodontitis. Drug Dev Res 2021;83:131-141. [PMID: 34227156 DOI: 10.1002/ddr.21851] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2021] [Revised: 05/29/2021] [Accepted: 06/17/2021] [Indexed: 11/10/2022]
15
Shah BM, Modi P, Trivedi P. Recent Medicinal Chemistry Approach for the Development of Dipeptidyl Peptidase IV Inhibitors. Curr Med Chem 2021;28:3595-3621. [PMID: 33045957 DOI: 10.2174/0929867327666201012153255] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2020] [Revised: 09/01/2020] [Accepted: 09/07/2020] [Indexed: 11/22/2022]
16
Petrou A, Fesatidou M, Geronikaki A. Thiazole Ring-A Biologically Active Scaffold. Molecules 2021;26:3166. [PMID: 34070661 PMCID: PMC8198555 DOI: 10.3390/molecules26113166] [Citation(s) in RCA: 67] [Impact Index Per Article: 22.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 05/15/2021] [Accepted: 05/20/2021] [Indexed: 11/16/2022]  Open
17
Singh S, Mandal MK, Masih A, Saha A, Ghosh SK, Bhat HR, Singh UP. 1,3,5-Triazine: A versatile pharmacophore with diverse biological activities. Arch Pharm (Weinheim) 2021;354:e2000363. [PMID: 33760298 DOI: 10.1002/ardp.202000363] [Citation(s) in RCA: 37] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2020] [Revised: 02/05/2021] [Accepted: 02/12/2021] [Indexed: 12/14/2022]
18
Guan B, Jiang C. Design and development of 1,3,5-triazine derivatives as protective agent against spinal cord injury in rat via inhibition of NF-ĸB. Bioorg Med Chem Lett 2021;41:127964. [PMID: 33744436 DOI: 10.1016/j.bmcl.2021.127964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2021] [Revised: 02/26/2021] [Accepted: 03/10/2021] [Indexed: 10/21/2022]
19
Masih A, Agnihotri AK, Srivastava JK, Pandey N, Bhat HR, Singh UP. Discovery of novel 1,3,5-triazine as adenosine A2A receptor antagonist for benefit in Parkinson's disease. J Biochem Mol Toxicol 2020;35:e22659. [PMID: 33156955 DOI: 10.1002/jbt.22659] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2020] [Revised: 09/13/2020] [Accepted: 10/20/2020] [Indexed: 12/28/2022]
20
Masih A, Shrivastava JK, Bhat HR, Singh UP. Potent antibacterial activity of dihydydropyrimidine-1,3,5-triazines via inhibition of DNA gyrase and antifungal activity with favourable metabolic profile. Chem Biol Drug Des 2020;96:861-869. [PMID: 32333828 DOI: 10.1111/cbdd.13695] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2019] [Revised: 02/02/2020] [Accepted: 02/29/2020] [Indexed: 11/28/2022]
21
Bhat HR, Masih A, Shakya A, Ghosh SK, Singh UP. Design, synthesis, anticancer, antibacterial, and antifungal evaluation of 4‐aminoquinoline‐1,3,5‐triazine derivatives. J Heterocycl Chem 2019. [DOI: 10.1002/jhet.3791] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
22
Liu H, Long S, Rakesh KP, Zha GF. Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents. Eur J Med Chem 2019;185:111804. [PMID: 31675510 DOI: 10.1016/j.ejmech.2019.111804] [Citation(s) in RCA: 57] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2019] [Revised: 10/19/2019] [Accepted: 10/20/2019] [Indexed: 12/19/2022]
23
Kellert M, Worm DJ, Hoppenz P, Sárosi MB, Lönnecke P, Riedl B, Koebberling J, Beck-Sickinger AG, Hey-Hawkins E. Modular triazine-based carborane-containing carboxylic acids - synthesis and characterisation of potential boron neutron capture therapy agents made of readily accessible building blocks. Dalton Trans 2019;48:10834-10844. [PMID: 31246208 DOI: 10.1039/c9dt02130b] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
24
Hussain H, Abbas G, Green IR, Ali I. Dipeptidyl peptidase IV inhibitors as a potential target for diabetes: patent review (2015-2018). Expert Opin Ther Pat 2019;29:535-553. [PMID: 31203700 DOI: 10.1080/13543776.2019.1632290] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
25
Yan W, Zhao Y, He J. Anti‑breast cancer activity of selected 1,3,5‑triazines via modulation of EGFR‑TK. Mol Med Rep 2018;18:4175-4184. [PMID: 30152850 PMCID: PMC6172377 DOI: 10.3892/mmr.2018.9426] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2017] [Accepted: 02/28/2018] [Indexed: 12/15/2022]  Open
26
Kerru N, Singh-Pillay A, Awolade P, Singh P. Current anti-diabetic agents and their molecular targets: A review. Eur J Med Chem 2018;152:436-488. [PMID: 29751237 DOI: 10.1016/j.ejmech.2018.04.061] [Citation(s) in RCA: 185] [Impact Index Per Article: 30.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2017] [Revised: 04/17/2018] [Accepted: 04/30/2018] [Indexed: 12/22/2022]
27
Wang X, Yi Y, Lv Q, Zhang J, Wu K, Wu W, Zhang W. Novel 1,3,5-triazine derivatives exert potent anti-cervical cancer effects by modulating Bax, Bcl2 and Caspases expression. Chem Biol Drug Des 2017;91:728-734. [PMID: 29068538 DOI: 10.1111/cbdd.13133] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2017] [Revised: 09/26/2017] [Accepted: 10/14/2017] [Indexed: 12/15/2022]
28
Ahmadi F, Mirzaei P, Bazgir A. Cobalt-catalyzed isocyanide insertion cyclization to dihydrobenzoimidazotriazins. Tetrahedron Lett 2017. [DOI: 10.1016/j.tetlet.2017.09.088] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
29
Zheng XZ, Zhou JL, Ye J, Guo PP, Lin CS. Cardioprotective effect of novel sulphonamides-1,3,5-triazine conjugates against ischaemic-reperfusion injury via selective inhibition of MMP-9. Chem Biol Drug Des 2016;88:756-765. [PMID: 27317634 DOI: 10.1111/cbdd.12807] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2016] [Revised: 06/02/2016] [Accepted: 06/12/2016] [Indexed: 12/28/2022]
30
Mao ZW, Li QL, Wang P, Sun YL, Liu Y. Design and Development of Novel 4-(4-(1H-Tetrazol-5-yl)-1H-pyrazol-1-yl)-6-morpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine as Cardiotonic Agent via Inhibition of PDE3. Arch Pharm (Weinheim) 2016;349:268-76. [PMID: 26934198 DOI: 10.1002/ardp.201500388] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2015] [Revised: 01/20/2016] [Accepted: 01/26/2016] [Indexed: 11/07/2022]
31
Gao HD, Liu P, Yang Y, Gao F. Sulfonamide-1,3,5-triazine–thiazoles: discovery of a novel class of antidiabetic agents via inhibition of DPP-4. RSC Adv 2016. [DOI: 10.1039/c6ra15948f] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]  Open
32
Guo W. Direct oxidative coupling of amidine hydrochlorides and methylarenes: TBHP-mediated synthesis of substituted 1,3,5-triazines under metal-free conditions. Org Biomol Chem 2015;13:10285-9. [DOI: 10.1039/c5ob01799h] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA